ARTICLE | Company News
Management tracks
September 4, 2015 11:10 PM UTC
Musculoskeletal company Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) hired Ralf Rosskamp as CMO. Rosskamp was VP of global clinical development at NPS Pharmaceuticals Inc., which Shire plc (LSE:SHP; NASDAQ;SHPG) acquired.
The Crescendo Biosciences unit of Myriad Genetics Inc. (NASDAQ:MYGN) named Elana Hitraya CMO effective Oct. 1. Hitraya was group medical director of rheumatology and immunology at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). ...